
business
Novartis Announces 3% Q2 Sales Growth to $14.4 Billion, Fueled by New Treatments
Novartis has announced that its second-quarter sales in 2026 have exceeded expectations, driven by the introduction of new treatments.
Topic
Latest news and analysis on “new treatments”.

Novartis has announced that its second-quarter sales in 2026 have exceeded expectations, driven by the introduction of new treatments.